Skip to main content

Market Overview

Intuitive Surgical Details New Study That 'Provides Compelling And Valuable Evidence' On The Advantages Of Robotic-Assisted Surgery

Share:
Intuitive Surgical Details New Study That 'Provides Compelling And Valuable Evidence' On The Advantages Of Robotic-Assisted Surgery

Intuitive Surgical, Inc. (NASDAQ: ISRG) detailed the results of a study on Monday, which support its robotic assisted surgery devices.

The data evaluated 2,300 robotic-assisted, 9,745 abdominal, 8,121 vaginal and 11,952 laparoscopic hysterectomies.

According to Intuitive Surgical, women undergoing benign hysterectomies by the company's da Vinci Surgical Systems had "better outcomes and experienced fewer complications" relative to the conventional surgical methods.

The study compared 30-day outcomes from robotic-assisted surgeries and those performed by high-volume surgeons.

Related Link: Weniger Plastic Surgery Launches Advanced New Skin Care Line Delivering Superior Results

"It's long been clear that minimally invasive hysterectomy can help reduce complications and speed recovery. But past studies comparing open and minimally invasive approaches compared less experienced robotic-assisted surgeons with colleagues in other approaches," said Peter Lim, M.D., FACOG, the Center of Hope, Renown Regional Medical Center, Nevada. "This study is designed to compare only the outcomes of similarly experienced surgeons, regardless of surgical approach, which provides a much more accurate picture of comparative effectiveness."

"This study provides compelling and valuable evidence on the advantages of robotic-assisted benign hysterectomy," said Myriam Curet, M.D., senior vice president, Chief Medical Officer at Intuitive Surgical. "For women undergoing these procedures, the benefits of robotic-assisted surgery shown in this study carry real and tangible results for their recovery and return to everyday life."

Shares of Intuitive Surgical were trading nearly flat at $567.68 Monday afternoon.

Image Credit: Public Domain

 

Related Articles (ISRG)

View Comments and Join the Discussion!

Posted-In: Biotech Long Ideas News Health Care Markets Movers Tech Trading Ideas Best of Benzinga

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com